Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG

FEMS Immunology and Medical Microbiology

Volumn 27, Issue 4, 2000, Pages 283-289

  Hess, Jürgen ^a,b   Grode, Leander ^a   Hellwig, Jacqueline ^a   Conradt, Peter ^b   Gentschev, Ivo ^c   Goebel, Werner ^c   Ladel, Christoph ^b   Kaufmann, Stefan H E ^a,b  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Protection; Recombinant Salmonella; Tuberculosis vaccine

Indexed keywords

BACTERIAL PROTEIN; BCG VACCINE; CYTOKINE; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; IMMUNE RESPONSE; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT PLASMID; SALMONELLA TYPHIMURIUM; SPLEEN CELL; TUBERCULOSIS; VACCINATION;

ACYLTRANSFERASES; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; PLASMIDS; SALMONELLA TYPHIMURIUM; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 0034017763     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00205-9     Document Type: Article

References (41)

1. The world health report (1999) Making a difference. ISBN 92 4 1561947, ISSN 1020-3311.
2. Calmette A., Guerin C., Negre L., Boquet A. Sur la vaccination prevente des enfants nouveau-nes contre la tuberculose par le BCG. Ann. Inst. Pasteur. 3:1927;201.
3. Coldlitz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA. 271:1994;698-702.
4. Horwitz M.A. A new TB vaccine. Immunologist. 5:1997;15-20.
5. Sturgill-Koszycki S., Schlesinger P.H., Chakraborty P., Haddix P.L., Collins H.L., Fok A.K., Allen R.D., Gluck S.L., Heuser J., Russell D.G. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science. 263:1994;678-681.
6. Deretic V., Fratte R.A. Mycobacterium tuberculosis phagosome. Mol. Microbiol. 31:1999;1603-1609.
7. Hmama Z., Gabathuler R., Jeffries W.A., de Jong G., Reiner N.E. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J. Immunol. 161:1998;4882-4893.
8. Pancholi P., Mirza A., Bhardwaj N., Steinman R.M. Sequestration from immune CD4 T cells of mycobacteria growing in human macrophages. Science. 260:1993;984-986.
9. Kaufmann S.H.E. Tuberculosis: The role of the immune response. Immunologist. 1:1993;109-114.
10. Hess J., Kaufmann S.H.E. Vaccination strategies against intracellular microbes. FEMS Microbiol. Immunol. 7:1993;95-103.
11. Wiker H.G., Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol. Rev. 56:1992;648-661.
12. Huygen K., Palfliet K., Jurion F., Hilgers J., ten Berg R., van Vooren J.-P., De Bruyn J. Specific lymphoproliferation, γ interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis Bacillus Calmette-Guerin. Infect. Immun. 56:1988;3196-3200.
13. Launois P., DeLeys R., Niang M.N., Drowart A., Andrien M., Dierckx P., Cartel P., Sarthou J.L., Van Vooren J.P., Huygen K. T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect. Immun. 62:1994;3679-3687.
14. Launois P., Niang M.N., De Bruyn J., Sarthou J.L., Rivier F., Drowart A., Van Vooren J.P., Millan J., Huygen K. The major secreted antigen complex (Ag 85) from Mycobacterium bovis bacille Calmette-Guerin is associated with protective T cells in leprosy: a follow-up study of 45 household contacts. J. Infect. Dis. 167:1993;1160-1167.
15. Baldwin S.L., D'Souza C., Roberts A.D., Kelly B.P., Frank A.A., Lui M.A., Ulmer J.B., Huygen K., McMurray D., Orme I.M. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66:1998;2951-2959.
16. Horwitz M.A., Lee B.-W.E., Dillon B.J., Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins against Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 92:1995;1530-1534.
17. Huygen K., Content J., Denis O., Montgomery D.L., et al. Immunogenicity and protective efficacy of tuberculosis DNA vaccine. Nat. Med. 2:1996;893-898.
18. Denis O., Tanghe A., Palfliet K., Jurion F., van den Berg T.P., Vanonckelen A., Ooms J., Saman E., Ulmer J.B., Content J., Huygen K. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4 and CD8 T-cell epitopic repertoire broader than that stimulates by Mycobacterium tuberculosis H37Rv infection. Infect. Immun. 66:1998;1527-1533.
19. Kamath A.T., Feng C.G., MacDonald M., Briscoe H., Britton W.J. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect. Immun. 67:1999;1702-1707.
20. Belisle J.T., Vissa V.D., Sievert T., Takayama K., Brennan P.J., Besra G.S. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science. 276:1997;1420-1422.
21. Matsuo K., Yamaguchi R., Yamazaki A., Tasaka H., Yamada T. Cloning and expression of the Mycobacterium bovis BCG gene for extracellular α-antigen. J. Bacteriol. 170:1988;3847-3854.
22. Borremans M., De Wit G., Volckaert G., Ooms J., De Bryun J., Huygen K., Van Vooren J.-P., Stelandre M., Verhofstadt R., Content J. Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis. Infect. Immun. 57:1989;3123-3130.
23. Content J., de la Cuvellerie A., de Wit L., Vincent-Levy-Frébault V., Ooms J., de Bryn J. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning and sequence determination, and genomic organization of the gene coding for antig 85-C of M. tuberculosis. Infect. Immun. 59:1991;3205-3212.
24. Harth G., Lee B.Y., Wang J., Clemens D.L., Horwitz M.A. Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect. Immun. 64:1997;3038-3047.
25. Hess, J. and Kaufmann, S.H.E. (1997) Principles of cell-mediated immunity underlying vaccination strategies against intracellular pathogens. In: Host Response to Intracellular Pathogens (Kaufmann, S.H.E., Ed.), pp. 75-94. R.G. Landes Company, Austin, TX.
26. Hess J., Gentschev I., Miko D., Welzel M., Ladel C., Goebel W., Kaufmann S.H.E. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine-induced protection against listeriosis. Proc. Natl. Acad. Sci. USA. 93:1996;1458-1463.
27. Hess J., Dietrich G., Gentschev I., Miko D., Goebel W., Kaufmann S.H.E. Protection against murine listeriosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the naturally somatic antigen superoxide dismutase. Infect. Immun. 65:1997;1286-1292.
28. Gentschev I., Mollenkopf H., Sokolovic Z., Hess J., Kaufmann S.H.E., Goebel W. Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway. Gene. 179:1996;133-138.
29. Hormaeche, C. and Khan, C.M.A. (1996) Recombinant bacteria as vaccine carriers of heterologous antigens. In: Concepts in Vaccine Development (Kaufmann, S.H.E., Ed.), pp. 327-349. Walter de Gruyter, Berlin.
30. Hoiseth S.K., Stocker B.A.D. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as a vaccine. Nature. 291:1981;238-241.
31. Hess J., Wels W., Vogel V., Goebel W. Nucleotide sequence of a plasmid-encoded hemolysin determinant and its comparison with a corresponding chromosomal hemolysin sequence. FEMS Lett. 34:1986;1-11.
32. Stover C.K., de la Cruz V.F., Fuerst T.R., Burlein J.E., Benson L.A., Bennett L.T., Bansal G.P., Youing J.F., Lee M.H., Hatfull G.F., et al. New use of BCG for recombinant vaccines. Nature. 351:1991;456-460.
33. Gentschev I., Sokolovic Z., Mollenkopf H.-J., Demuth A., Hess J., Kaufmann S.H.E., Kuhn M., Krohne G.F., Goebel W. Salmonella secreting active listeriolysin changes its intracellular localization. Infect. Immun. 63:1995;4202-4205.
34. Ladel C., Daugelat S., Kaufmann S.H.E. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 25:1995;377-384.
35. Szalay G., Ladel C.H., Blum C., Kaufmann S.H.E. IL-4 neutralization or TNF-α treatment amiliorate disease by an intracellular pathogen in IFN-γ receptor-defcient mice. J. Immunol. 157:1996;4746-4750.
36. Bermudez L.E., Kaplan G. Recombinant cytokines for controlling mycobacterial infections. Trends Microbiol. 3:1995;22-26.
37. Kaufmann S.H.E., Ladel C.H., Flesch I.E.A. T cells and cytokines in intracellular bacterial infections: experiences with Mycobacterium bovis BCG. Ciba Found. Symp. 195:1995;123-132.
38. Pamer E.G. Cell-mediated immunity: The role of bacterial secretion. Curr. Biol. 8:1998;R457-R460.
39. Kaufmann, S.H.E. (1998) Immunity to intracellular bacteria. In: Fundamental Immunology (Paul, W.E., Ed.), 4th edn., pp. 1335-1371. Lippincott-Raven, Philadelphia, PA.
40. Hess J., Miko D., Gentschev I., Dietrich G., Goebel W., Mollenkopf H.-J., Ladel C.H., Kaufmann S.H.E. Modulation of antigen display by attenuated Salmonella typhimurium strains and its impact on protective immunity against listeriosis. Behring Inst. Mitt. 98:1997;160-171.
41. Zhu X., Venkataprasad N., Ivanyi J., Vordermeier H.M. Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis. Immunology. 92:1997;6-12.